APO Research
Talk to an analyst

APO RESEARCH · REPORT

Xingnaojing Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Xingnaojing Injection Market Outlook and Growth Opportunities 2026

29 December 2025195 pages

Choose your research edition.

Industry ResearchXingnaojing Injection Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Xingnaojing Injection Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Xingnaojing Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Xingnaojing Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Xingnaojing Injection Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Xingnaojing Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Xingnaojing Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Xingnaojing Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Xingnaojing Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Xingnaojing Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Xingnaojing Injection market include Wuxi Jiyushanhe Pharmaceutical Co., Ltd., Henan Tiandi Pharmaceutical Co., Ltd. and Dali Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Xingnaojing Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Xingnaojing Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Xingnaojing Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Xingnaojing Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Xingnaojing Injection Segment by Company

Wuxi Jiyushanhe Pharmaceutical Co., Ltd.

Henan Tiandi Pharmaceutical Co., Ltd.

Dali Pharmaceutical Co., Ltd.

Xingnaojing Injection Segment by Type

5ml

10ml

Xingnaojing Injection Segment by Application

Hospital

Clinic

Other

Xingnaojing Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Xingnaojing Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Xingnaojing Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Xingnaojing Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Xingnaojing Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Xingnaojing Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Xingnaojing Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Xingnaojing Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Xingnaojing Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Xingnaojing Injection industry.

Chapter 3: Detailed analysis of Xingnaojing Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Xingnaojing Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Xingnaojing Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Xingnaojing Injection Industry Trends Table 2. Xingnaojing Injection Industry Drivers Table 3. Xingnaojing Injection Industry Opportunities and Challenges Table 4. Xingnaojing Injection Industry Restraints Table 5. Global Xingnaojing Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Xingnaojing Injection Revenue Share by Company (2021-2026) Table 7. Global Xingnaojing Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Xingnaojing Injection Sales Volume Share by Company (2021-2026) Table 9. Global Xingnaojing Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Xingnaojing Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Xingnaojing Injection Key Company Manufacturing Base & Headquarters Table 12. Global Xingnaojing Injection Company, Product Type & Application Table 13. Global Xingnaojing Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Xingnaojing Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5ml Table 18. Significant Companies of 10ml Table 19. Global Xingnaojing Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Xingnaojing Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Xingnaojing Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Xingnaojing Injection Sales Volume Share by Type (2021-2026) Table 23. Global Xingnaojing Injection Sales Volume Share by Type (2027-2032) Table 24. Global Xingnaojing Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Xingnaojing Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Xingnaojing Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Xingnaojing Injection Sales Value Share by Type (2021-2026) Table 28. Global Xingnaojing Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Xingnaojing Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Xingnaojing Injection Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Xingnaojing Injection Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Xingnaojing Injection Sales Volume Share by Application (2021-2026) Table 36. Global Xingnaojing Injection Sales Volume Share by Application (2027-2032) Table 37. Global Xingnaojing Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Xingnaojing Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Xingnaojing Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Xingnaojing Injection Sales Value Share by Application (2021-2026) Table 41. Global Xingnaojing Injection Sales Value Share by Application (2027-2032) Table 42. Global Xingnaojing Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Xingnaojing Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Xingnaojing Injection Sales Market Share by Region (2021-2026) Table 45. Global Xingnaojing Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Xingnaojing Injection Sales Market Share by Region (2027-2032) Table 47. Global Xingnaojing Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Xingnaojing Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Xingnaojing Injection Sales Value Share by Region (2021-2026) Table 50. Global Xingnaojing Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Xingnaojing Injection Sales Value Share by Region (2027-2032) Table 52. Global Xingnaojing Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Xingnaojing Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Xingnaojing Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Xingnaojing Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Xingnaojing Injection Sales by Country (2021-2026) & (K Units) Table 57. Global Xingnaojing Injection Sales Market Share by Country (2021-2026) Table 58. Global Xingnaojing Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Xingnaojing Injection Sales Market Share by Country (2027-2032) Table 60. Global Xingnaojing Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Xingnaojing Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Xingnaojing Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Xingnaojing Injection Sales Value Market Share by Country (2027-2032) Table 64. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Company Information Table 65. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Business Overview Table 66. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Xingnaojing Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Xingnaojing Injection Product Portfolio Table 68. Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Recent Development Table 69. Henan Tiandi Pharmaceutical Co., Ltd. Company Information Table 70. Henan Tiandi Pharmaceutical Co., Ltd. Business Overview Table 71. Henan Tiandi Pharmaceutical Co., Ltd. Xingnaojing Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Henan Tiandi Pharmaceutical Co., Ltd. Xingnaojing Injection Product Portfolio Table 73. Henan Tiandi Pharmaceutical Co., Ltd. Recent Development Table 74. Dali Pharmaceutical Co., Ltd. Company Information Table 75. Dali Pharmaceutical Co., Ltd. Business Overview Table 76. Dali Pharmaceutical Co., Ltd. Xingnaojing Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Dali Pharmaceutical Co., Ltd. Xingnaojing Injection Product Portfolio Table 78. Dali Pharmaceutical Co., Ltd. Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Xingnaojing Injection Distributors List Table 82. Xingnaojing Injection Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Xingnaojing Injection Product Image Figure 2. Global Xingnaojing Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Xingnaojing Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Xingnaojing Injection Sales (2021-2032) & (K Units) Figure 5. Global Xingnaojing Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Xingnaojing Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5ml Image Figure 10. 10ml Image Figure 11. Global Xingnaojing Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Xingnaojing Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Xingnaojing Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Xingnaojing Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Xingnaojing Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Xingnaojing Injection Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Xingnaojing Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Xingnaojing Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Xingnaojing Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Xingnaojing Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Xingnaojing Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Xingnaojing Injection Sales Value Share by Application (2021-2032) Figure 26. Global Xingnaojing Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Xingnaojing Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Xingnaojing Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Xingnaojing Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Xingnaojing Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Xingnaojing Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Xingnaojing Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Xingnaojing Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Xingnaojing Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Xingnaojing Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Xingnaojing Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Xingnaojing Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Xingnaojing Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Xingnaojing Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Xingnaojing Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Xingnaojing Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Xingnaojing Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 5ml
  • 10ml
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Wuxi Jiyushanhe Pharmaceutical Co., Ltd.
  • Henan Tiandi Pharmaceutical Co., Ltd.
  • Dali Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Xingnaojing Injection Sales Value (2021-2032)
  4. 1.2.2 Global Xingnaojing Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Xingnaojing Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Xingnaojing Injection Market Dynamics
  1. 2.1 Xingnaojing Injection Industry Trends
  2. 2.2 Xingnaojing Injection Industry Drivers
  3. 2.3 Xingnaojing Injection Industry Opportunities and Challenges
  4. 2.4 Xingnaojing Injection Industry Restraints
3 Xingnaojing Injection Market by Company
  1. 3.1 Global Xingnaojing Injection Company Revenue Ranking in 2025
  2. 3.2 Global Xingnaojing Injection Revenue by Company (2021-2026)
  3. 3.3 Global Xingnaojing Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Xingnaojing Injection Average Price by Company (2021-2026)
  5. 3.5 Global Xingnaojing Injection Company Ranking (2024-2026)
  6. 3.6 Global Xingnaojing Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Xingnaojing Injection Company Product Type and Application
  8. 3.8 Global Xingnaojing Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Xingnaojing Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Xingnaojing Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Xingnaojing Injection Market by Type
  1. 4.1 Xingnaojing Injection Type Introduction
  2. 4.1.1 5ml
  3. 4.1.2 10ml
  4. 4.2 Global Xingnaojing Injection Sales Volume by Type
  5. 4.2.1 Global Xingnaojing Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Xingnaojing Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Xingnaojing Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Xingnaojing Injection Sales Value by Type
  9. 4.3.1 Global Xingnaojing Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Xingnaojing Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Xingnaojing Injection Sales Value Share by Type (2021-2032)
5 Xingnaojing Injection Market by Application
  1. 5.1 Xingnaojing Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Xingnaojing Injection Sales Volume by Application
  6. 5.2.1 Global Xingnaojing Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Xingnaojing Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Xingnaojing Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Xingnaojing Injection Sales Value by Application
  10. 5.3.1 Global Xingnaojing Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Xingnaojing Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Xingnaojing Injection Sales Value Share by Application (2021-2032)
6 Xingnaojing Injection Regional Sales and Value Analysis
  1. 6.1 Global Xingnaojing Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Xingnaojing Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Xingnaojing Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Xingnaojing Injection Sales by Region (2027-2032)
  5. 6.3 Global Xingnaojing Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Xingnaojing Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Xingnaojing Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Xingnaojing Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Xingnaojing Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Xingnaojing Injection Sales Value (2021-2032)
  12. 6.6.2 North America Xingnaojing Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Xingnaojing Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Xingnaojing Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Xingnaojing Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Xingnaojing Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Xingnaojing Injection Sales Value (2021-2032)
  21. 6.9.2 South America Xingnaojing Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Xingnaojing Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Xingnaojing Injection Sales Value Share by Country, 2025 VS 2032
7 Xingnaojing Injection Country-level Sales and Value Analysis
  1. 7.1 Global Xingnaojing Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Xingnaojing Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Xingnaojing Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Xingnaojing Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Xingnaojing Injection Sales by Country (2027-2032)
  6. 7.4 Global Xingnaojing Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Xingnaojing Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Xingnaojing Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Xingnaojing Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Xingnaojing Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Xingnaojing Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wuxi Jiyushanhe Pharmaceutical Co., Ltd.
  2. 8.1.1 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Xingnaojing Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Xingnaojing Injection Product Portfolio
  6. 8.1.5 Wuxi Jiyushanhe Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Henan Tiandi Pharmaceutical Co., Ltd.
  8. 8.2.1 Henan Tiandi Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Henan Tiandi Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Henan Tiandi Pharmaceutical Co., Ltd. Xingnaojing Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Henan Tiandi Pharmaceutical Co., Ltd. Xingnaojing Injection Product Portfolio
  12. 8.2.5 Henan Tiandi Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Dali Pharmaceutical Co., Ltd.
  14. 8.3.1 Dali Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Dali Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Dali Pharmaceutical Co., Ltd. Xingnaojing Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Dali Pharmaceutical Co., Ltd. Xingnaojing Injection Product Portfolio
  18. 8.3.5 Dali Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Xingnaojing Injection Value Chain Analysis
  2. 9.1.1 Xingnaojing Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Xingnaojing Injection Sales Mode & Process
  6. 9.2 Xingnaojing Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Xingnaojing Injection Distributors
  9. 9.2.3 Xingnaojing Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst